209 related articles for article (PubMed ID: 27596816)
21. MicroRNA-194 represses glioma cell epithelial‑to‑mesenchymal transition by targeting Bmi1.
Zhang X; Wei C; Li J; Liu J; Qu J
Oncol Rep; 2017 Mar; 37(3):1593-1600. PubMed ID: 28098896
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene.
He X; Dong Y; Wu CW; Zhao Z; Ng SS; Chan FK; Sung JJ; Yu J
Mol Med; 2013 Feb; 18(1):1491-8. PubMed ID: 23255074
[TBL] [Abstract][Full Text] [Related]
23. Role of miR-15a in intervertebral disc degeneration through targeting MAP3K9.
Cai P; Yang T; Jiang X; Zheng M; Xu G; Xia J
Biomed Pharmacother; 2017 Mar; 87():568-574. PubMed ID: 28081468
[TBL] [Abstract][Full Text] [Related]
24. Anticancer effects of miR-200c in colorectal cancer through BMI1.
Karimi Mazraehshah M; Tavangar SM; Saidijam M; Amini R; Bahreini F; Karimi Dermani F; Najafi R
J Cell Biochem; 2018 Dec; 119(12):10005-10012. PubMed ID: 30171714
[TBL] [Abstract][Full Text] [Related]
25. miR-15a/miR-16 down-regulates BMI1, impacting Ub-H2A mediated DNA repair and breast cancer cell sensitivity to doxorubicin.
Patel N; Garikapati KR; Pandita RK; Singh DK; Pandita TK; Bhadra U; Bhadra MP
Sci Rep; 2017 Jun; 7(1):4263. PubMed ID: 28655885
[TBL] [Abstract][Full Text] [Related]
26. MiRNA-15a mediates cell cycle arrest and potentiates apoptosis in breast cancer cells by targeting synuclein-γ.
Li P; Xie XB; Chen Q; Pang GL; Luo W; Tu JC; Zheng F; Liu SM; Han L; Zhang JK; Luo XY; Zhou X
Asian Pac J Cancer Prev; 2014; 15(16):6949-54. PubMed ID: 25169552
[TBL] [Abstract][Full Text] [Related]
27. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
Dimri M; Cho JH; Kang M; Dimri GP
J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
[TBL] [Abstract][Full Text] [Related]
28. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
29. BCL2 promotor methylation and miR-15a/16-1 upregulation is associated with sanguinarine-induced apoptotic death in rat HSC-T6 cells.
Zhang DS; Li YY; Chen XJ; Li YJ; Liu ZY; Xie WJ; Sun ZL
J Pharmacol Sci; 2015 Jan; 127(1):135-44. PubMed ID: 25704029
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-630 inhibits breast cancer progression by directly targeting BMI1.
Gong XF; Yu AL; Tang J; Wang CL; He JR; Chen GQ; Zhao Q; He M; Zhou CX
Exp Cell Res; 2018 Jan; 362(2):378-385. PubMed ID: 29208462
[TBL] [Abstract][Full Text] [Related]
31. miR-203 inhibits cell growth and regulates G1/S transition by targeting Bmi-1 in myeloma cells.
Wu SQ; Niu WY; Li YP; Huang HB; Zhan R
Mol Med Rep; 2016 Nov; 14(5):4795-4801. PubMed ID: 27748826
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
33. miR-15a induces cell apoptosis by targeting BCL2L2 and BCL2 in HPV-positive hypopharyngeal squamous cell carcinoma.
Lu W; Feng L; Zhang Y; Ma Y; Li P; Wang Y; Du Y; Chen X; Wu S; Zhao G; Lou W
Oncol Rep; 2016 Oct; 36(4):2169-76. PubMed ID: 27573302
[TBL] [Abstract][Full Text] [Related]
34. Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.
Yang J; Jiang H; Wang C; Yang B; Zhao L; Hu D; Qiu G; Dong X; Xiao B
Biomed Pharmacother; 2015 May; 72():125-34. PubMed ID: 26054686
[TBL] [Abstract][Full Text] [Related]
35. MiR-203 inhibits melanoma invasive and proliferative abilities by targeting the polycomb group gene BMI1.
Chang X; Sun Y; Han S; Zhu W; Zhang H; Lian S
Biochem Biophys Res Commun; 2015 Jan; 456(1):361-6. PubMed ID: 25475727
[TBL] [Abstract][Full Text] [Related]
36. Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.
Wang J; Zhang X; Shi J; Cao P; Wan M; Zhang Q; Wang Y; Kridel SJ; Liu W; Xu J; Zhang Q; Sui G
Oncotarget; 2016 Nov; 7(48):78566-78576. PubMed ID: 27713175
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways.
Srivastava SK; Bhardwaj A; Arora S; Tyagi N; Singh S; Andrews J; McClellan S; Wang B; Singh AP
Br J Cancer; 2015 Aug; 113(4):660-8. PubMed ID: 26247574
[TBL] [Abstract][Full Text] [Related]
38. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-221, -30d, and -15a contributes to pathogenesis of prostate cancer by targeting Bmi-1.
Xuan H; Xue W; Pan J; Sha J; Dong B; Huang Y
Biochemistry (Mosc); 2015 Mar; 80(3):276-83. PubMed ID: 25761682
[TBL] [Abstract][Full Text] [Related]
40. Induction of cell proliferation and survival genes by estradiol-repressed microRNAs in breast cancer cells.
Yu X; Zhang X; Dhakal IB; Beggs M; Kadlubar S; Luo D
BMC Cancer; 2012 Jan; 12():29. PubMed ID: 22260523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
